News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
197,618 Results
Type
Article (13806)
Company Profile (36)
Press Release (183776)
Multimedia
Podcasts (34)
Webinars (1)
Section
Business (63306)
Career Advice (622)
Deals (8830)
Drug Delivery (40)
Drug Development (36892)
Employer Resources (41)
FDA (4901)
Job Trends (4624)
News (110389)
Policy (8167)
Tag
Academia (892)
Accelerated approval (19)
Adcomms (14)
Allergies (61)
Alliances (12225)
ALS (77)
Alzheimer's disease (575)
Antibody-drug conjugate (ADC) (139)
Approvals (5043)
Artificial intelligence (158)
Autoimmune disease (68)
Automation (12)
Bankruptcy (68)
Best Places to Work (3978)
BIOSECURE Act (15)
Biosimilars (58)
Biotechnology (28)
Bladder cancer (96)
Brain cancer (28)
Breast cancer (323)
Cancer (2302)
Cardiovascular disease (160)
Career advice (531)
Career pathing (14)
CAR-T (124)
CDC (14)
Celiac Disease (1)
Cell therapy (303)
Cervical cancer (13)
Clinical research (33091)
Collaboration (488)
Company closure (2)
Compensation (160)
Complete response letters (27)
COVID-19 (1180)
CRISPR (55)
C-suite (151)
Cystic fibrosis (55)
Data (2794)
Denatured (4)
Depression (58)
Diabetes (184)
Diagnostics (2448)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (58)
Drug pricing (60)
Drug shortages (6)
Duchenne muscular dystrophy (89)
Earnings (42558)
Editorial (21)
Employer branding (8)
Employer resources (37)
Events (22574)
Executive appointments (160)
FDA (6206)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (5)
Funding (386)
Gene editing (126)
Generative AI (15)
Gene therapy (264)
GLP-1 (411)
Government (1352)
Grass and pollen (4)
Guidances (255)
Healthcare (4918)
HIV (19)
Huntington's disease (23)
IgA nephropathy (49)
Immunology and inflammation (109)
Immuno-oncology (24)
Indications (46)
Infectious disease (1273)
Inflammatory bowel disease (61)
Inflation Reduction Act (10)
Influenza (37)
Intellectual property (63)
Interviews (113)
IPO (4983)
IRA (22)
Job creations (801)
Job search strategy (422)
JPM (19)
Kidney cancer (11)
Labor market (28)
Layoffs (237)
Leadership (6)
Legal (1019)
Liver cancer (53)
Longevity (2)
Lung cancer (359)
Lymphoma (195)
Machine learning (12)
Management (9)
Manufacturing (198)
MASH (81)
Medical device (3013)
Medtech (3025)
Mergers & acquisitions (4130)
Metabolic disorders (525)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (125)
Neuropsychiatric disorders (49)
Neuroscience (1133)
NextGen: Class of 2026 (1416)
Non-profit (991)
Now hiring (9)
Obesity (252)
Opinion (95)
Ovarian cancer (70)
Pain (66)
Pancreatic cancer (115)
Parkinson's disease (122)
Partnered (6)
Patents (107)
Patient recruitment (209)
Peanut (23)
People (9222)
Pharmaceutical (8)
Pharmacy benefit managers (7)
Phase 1 (8944)
Phase 2 (14527)
Phase 3 (13029)
Pipeline (2515)
Policy (88)
Postmarket research (824)
Preclinical (2678)
Press Release (26)
Prostate cancer (108)
Psychedelics (20)
Radiopharmaceuticals (74)
Rare diseases (363)
Real estate (1165)
Recruiting (21)
Regulatory (7464)
Reports (19)
Research institute (888)
Resumes & cover letters (116)
Rett syndrome (11)
RNA editing (3)
RSV (34)
Schizophrenia (81)
Series A (70)
Series B (44)
Service/supplier (1)
Sickle cell disease (50)
Special edition (7)
Spinal muscular atrophy (80)
Sponsored (13)
Startups (898)
Stomach cancer (10)
Supply chain (24)
Tariffs (25)
The Weekly (29)
Vaccines (390)
Venture capital (31)
Weight loss (170)
Women's health (13)
Worklife (6)
Date
Today (1)
Last 7 days (138)
Last 30 days (588)
Last 365 days (10281)
2026 (809)
2025 (10500)
2024 (12106)
2023 (13637)
2022 (17596)
2021 (18009)
2020 (15960)
2019 (12393)
2018 (9224)
2017 (10434)
2016 (9207)
2015 (10662)
2014 (7337)
2013 (5635)
2012 (5966)
2011 (6195)
2010 (5598)
Location
Africa (226)
Alabama (25)
Alaska (2)
Arizona (63)
Arkansas (2)
Asia (12522)
Australia (2048)
California (4099)
Canada (957)
China (412)
Colorado (142)
Connecticut (162)
Delaware (134)
Europe (28243)
Florida (535)
Georgia (107)
Hawaii (2)
Idaho (11)
Illinois (238)
India (16)
Indiana (176)
Iowa (9)
Japan (184)
Kansas (37)
Kentucky (12)
Louisiana (8)
Maine (33)
Maryland (432)
Massachusetts (2708)
Michigan (77)
Minnesota (141)
Mississippi (1)
Missouri (40)
Montana (9)
Nebraska (7)
Nevada (31)
New Hampshire (20)
New Jersey (1251)
New Mexico (13)
New York (1047)
North Carolina (451)
North Dakota (7)
Northern California (2059)
Ohio (76)
Oregon (6)
Pennsylvania (704)
Puerto Rico (10)
Rhode Island (11)
South America (319)
South Carolina (13)
Southern California (1563)
Tennessee (35)
Texas (568)
United States (13452)
Utah (89)
Virginia (60)
Washington D.C. (14)
Washington State (287)
Wisconsin (29)
197,618 Results for "second genome".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Lilly Establishes up to $1.9B Repertoire Deal in Second Immune Play of 2026
The Repertoire partnership is Lilly’s second immunology play of the year, after the acquistion of Ventyx in early January for a pipeline of NLRP3 assets.
January 29, 2026
·
2 min read
·
Tristan Manalac
Press Releases
10x Genomics Reports Second Quarter 2025 Financial Results
August 8, 2025
·
11 min read
Press Releases
GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy
January 6, 2026
·
3 min read
Press Releases
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
January 8, 2026
·
7 min read
Press Releases
10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025
July 11, 2025
·
1 min read
Press Releases
One Genomics and CiRA Foundation Announce Strategic Research Collaboration to Advance Precision Genome Engineering
January 9, 2026
·
2 min read
Press Releases
Merck Announces Second-Quarter 2026 Dividend
January 28, 2026
·
2 min read
Press Releases
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
January 1, 2026
·
8 min read
Press Releases
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
February 4, 2026
·
24 min read
Press Releases
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
January 30, 2026
·
18 min read
1 of 19,762
Next
